While the GWAS findings showed a significant association near PRKAA2, we could not identify filtered genomic variants linked to splicing; therefore, we cannot exclude the possibility of the differential transcript usage being a secondary response to DCM itself, or simply a result of canonical GT and AG splice site motifs present at the observed splice sites. The gene discussed is PRKAA2; the disease is familial dilated cardiomyopathy.